Mutations Flashcards
8;21
AML
15;17
APL
12;21
children’s ALL
9;22
PH+, either CML or B-all adult
CD5+
Increased in CLL
TRAP
Positive with hair cell leukemia
Rash Leukemia
Adult T Cell Leukemia
617 exon 4
PV
Pruritis
PV
LAP-
CML
CARL+
ET or primary myelofibrosis
CD30+
Hodgkins Lymphoma
ABVD risk
Coronary artery disease
Hodgkins staging
Ann Arbor
Lacunar cells
Nodular sclerosing
14;18
BRC2 in Follicular NHL
11;14
Cylcin D in Mantle NHL
8;14
C-Myc in Burkitt’s
Starry Sky
Burkitt’s
Sheets of large B cells
DLBCL
IL6
Multiple myeloma
RANK
Multiple Myeloma
IgM
Waldenstrom’s
14q32
Multiple Myeloma
4;14
Multiple Myeloma, high risk
Birbeck Granule
Tennis racket, Langerhan’s Cells
CD1A+ and S100+
Langerhan’s Cells
drug causing hand-foot syndrome
Capecitabine, pyrimidine analog
drug causing Hemorrhagic Cystitis
Cyclophosphamade, DNA Alkylator
drug causing Cardiotoxicity
Doxorubicin
drug causing Pulmonary fibrosis
Bleomycin
drug causing early menopause-like symptoms
Tamoxifen
drug causing clotting
Bevacizumab
anti-CD30 drug
Brentuximab
CTLA-4 function
turn off T cell in “effector” stage
B7 paired with
CD28
PD1/PDL1
Turns off T cell
CTLA4 blocker name
ipilimumab
drug causing hepatitis
ipilimumab (anti CTLA4)
PD1 blocker name
nivolumab
drug causing arthralgias
nivolumab (anti-PD1)
RAR-a
APL
Type M3 AML
APL
CD11+
Hairy Cell Leukemia
CD10+
Follicular NHL
G1 to S phase
Due to Cylcin D mutation in Mantle NHL
Richter’s Syndrome
SLL
3q27
DLBCL
Amyloidosis (primary)
Multiple Myeloma
Multiple myeloma tx
Thalidimide and bortezomib
Methyltrexate target
DHFR making TS
HER2 drug
trastuzimab
EGFR (2 drugs)
Erlotinib
Certuximab
VEGF drug
bevicizumab
BRAF drug
verumafenib
Anti-CD30
Brentuximab
CD3+
Langerhan’s (Letter-Siwe)